ALDH1B1 and neoplasm: Significantly, both the knockdown of the ALDH1B1 gene through CRISPR, as well as the inhibition of its enzymatic activity resulted in attenuated colon spheroid and xenograft tumor growth, accompanied by the downregulation of colorectal CSC markers, such as the KRT15 and DCLK1 [183].